Literature DB >> 30953971

Hepatitis C virus screening trends: A 2016 update of the National Health Interview Survey.

Monica L Kasting1, Anna R Giuliano2, Richard R Reich3, Richard G Roetzheim4, Linh M Duong5, Emmanuel Thomas6, David R Nelson7, Elizabeth Shenkman8, Susan T Vadaparampil9.   

Abstract

BACKGROUND: 50% of liver cancer is caused by hepatitis C virus (HCV). Baby boomers are at increased risk and are recommended for one-time HCV screening. However, <13% of baby boomers were screened in 2015.
MATERIALS AND METHODS: We are updating a previous study using 2013-2015 NHIS data to examine HCV screening prevalence by birth cohort, with 2016 data. We used logistic regression to evaluate whether HCV screening prevalence changed over time, stratified by birth cohort. RESULTS AND DISCUSSION: The sample consisted of 132,742 participants from 2013-2016. Screening increased in baby boomers from 11.9 to 14.1%. Odds of HCV screening for baby boomers was significantly associated with age, gender, race/ethnicity, and other variables and increased significantly with each subsequent year (aOR = 1.21, aOR = 1.33, aOR = 1.42, consecutively). While HCV screening is increasing over time, there is still room for improvement and future interventions should focus on increasing HCV screening among groups demonstrating significantly lower screening prevalence.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer screening; Health care utilization; Hepatitis C; Hepatocellular carcinoma; Population at risk; Survey methods; Trends; Viral hepatitis

Mesh:

Year:  2019        PMID: 30953971      PMCID: PMC6527446          DOI: 10.1016/j.canep.2019.03.007

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  14 in total

Review 1.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

2.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2012-08-17

3.  Update on mammography trends: comparisons of rates in 2000, 2005, and 2008.

Authors:  Nancy Breen; Jane F Gentleman; Jeannine S Schiller
Journal:  Cancer       Date:  2010-11-30       Impact factor: 6.860

4.  Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010.

Authors:  Reena Mahajan; Jian Xing; Stephen J Liu; Kathleen N Ly; Anne C Moorman; Loralee Rupp; Fujie Xu; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2014-02-12       Impact factor: 9.079

5.  Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.

Authors:  A Blythe Ryerson; Christie R Eheman; Sean F Altekruse; John W Ward; Ahmedin Jemal; Recinda L Sherman; S Jane Henley; Deborah Holtzman; Andrew Lake; Anne-Michelle Noone; Robert N Anderson; Jiemin Ma; Kathleen N Ly; Kathleen A Cronin; Lynne Penberthy; Betsy A Kohler
Journal:  Cancer       Date:  2016-03-09       Impact factor: 6.860

6.  Hepatitis C Virus Screening Trends: Serial Cross-Sectional Analysis of the National Health Interview Survey Population, 2013-2015.

Authors:  Monica L Kasting; Anna R Giuliano; Richard R Reich; Richard G Roetzheim; David R Nelson; Elizabeth Shenkman; Susan T Vadaparampil
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-03-27       Impact factor: 4.254

7.  Differences in cervical cancer screening knowledge, practices, and beliefs: An examination of survey responses.

Authors:  Monica L Kasting; Shannon Wilson; Terrell W Zollinger; Brian E Dixon; Nathan W Stupiansky; Gregory D Zimet
Journal:  Prev Med Rep       Date:  2016-12-21

8.  Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012.

Authors:  Susan L Stewart; Sandy L Kwong; Christopher L Bowlus; Tung T Nguyen; Annette E Maxwell; Roshan Bastani; Eric W Chak; Moon S Chen
Journal:  World J Gastroenterol       Date:  2016-10-14       Impact factor: 5.742

9.  State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs - United States, 2015-2016.

Authors:  Cecily A Campbell; Lauren Canary; Nicole Smith; Eyasu Teshale; A Blythe Ryerson; John W Ward
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-05-12       Impact factor: 17.586

10.  Estimates of state-level chronic hepatitis C virus infection, stratified by race and sex, United States, 2010.

Authors:  Eric W Hall; Eli S Rosenberg; Patrick S Sullivan
Journal:  BMC Infect Dis       Date:  2018-05-16       Impact factor: 3.090

View more
  6 in total

1.  The Association of Abnormal Liver Tests with Hepatitis C Testing in Primary Care.

Authors:  Andrew D Schreiner; John Bian; Jingwen Zhang; Z Merle Haulsee; Justin Marsden; Valerie Durkalski-Mauldin; Patrick D Mauldin; William P Moran; Don C Rockey
Journal:  Am J Med       Date:  2019-07-29       Impact factor: 4.965

2.  Hepatitis C Virus Screening: Factors Associated With Test Completion in a Large Academic Health Care System.

Authors:  Monica L Kasting; Shannon M Christy; Richard R Reich; Julie A Rathwell; Richard G Roetzheim; Susan T Vadaparampil; Anna R Giuliano
Journal:  Public Health Rep       Date:  2021-10-25       Impact factor: 3.117

3.  Testing for Hepatitis C Virus Infection Among Adults Aged ≥18 in the United States, 2013-2017.

Authors:  Hope King; J E Soh; William W Thompson; Jessica Rogers Brown; Karina Rapposelli; Claudia Vellozzi
Journal:  Public Health Rep       Date:  2021-10-04       Impact factor: 3.117

4.  Using the Electronic Health Record to Characterize the Hepatitis C Virus Care Cascade.

Authors:  Shannon M Christy; Richard R Reich; Julie A Rathwell; Susan T Vadaparampil; Kimberly A Isaacs-Soriano; Mark S Friedman; Richard G Roetzheim; Anna R Giuliano
Journal:  Public Health Rep       Date:  2021-04-08       Impact factor: 3.117

5.  Impact and costs of a hepatitis C virus screening programme for adults hospitalised at an academic medical centre.

Authors:  Timothy J Whitman; Cindy D Noyes; Andrew J Hale; Devika Singh; Stephen G DeVoe; Allen B Repp; Kristen K Pierce; Louis B Polish; Beth D Kirkpatrick; Jean Dejace; Lindsay M Smith; Tim Lahey; Christopher D Huston; Laura J Catoe; Prateek Ghatage; Sean Bullis; W Kemper Alston
Journal:  BMJ Open Qual       Date:  2021-02

6.  There's just not enough time: a mixed methods pilot study of hepatitis C virus screening among baby boomers in primary care.

Authors:  Monica L Kasting; Julie Rathwell; Kaitlyn M Gabhart; Jennifer Garcia; Richard G Roetzheim; Olveen Carrasquillo; Anna R Giuliano; Susan T Vadaparampil
Journal:  BMC Fam Pract       Date:  2020-12-02       Impact factor: 2.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.